International Journal of Pharmaceutical Research and Allied Sciences IJPRAS
ISSN: 2277-3657
DOI Prefix: 10.51847

International Journal of Pharmaceutical Research and Allied Sciences

About us

The International Journal of Pharmaceutical Research and Allied Sciences (IJPRAS) is an international double-blind peer-reviewed open access journal. The quarterly publishing journal is a multi-disciplinary pharmaceutical & scientific journal that serves scientific information, studies, and scientific outcomes of various international pharmaceutical & scientific industries, institutes and forums. 


The journal particularly aims to foster the dissemination of scientific information by publishing manuscripts related to current Pharmaceutical as well as allied sciences fields. It publishes full research papers presenting original, high quality research, critical review articles providing comprehensive analysis of research & development within a defined area. The journal provides an intellectual platform for discussion and dissemination of new ideas and latest research in pharmaceutical and allied sciences.

 

Aim and Scope

 

Aim:

The aim of the journal is to advance theoretical and empirical understanding in the field of pharmaceutical research and allied sciences by publishing high-quality, peer-reviewed articles. The journal seeks to bridge the gap between theoretical advancements and practical applications in pharmaceutical sciences and related disciplines.

Scope:

The journal focuses on original research and reviews in the following areas:

  1. Pharmaceutical Sciences:
    • Pharmaceutics, Formulation Science (Solids, Topical, Parenteral, NDDS)
    • Pharmacology & Toxicology
    • Medicinal Chemistry, Pharmacognosy, and Pharmacovigilance
    • Nanotechnology, Biopharmaceutics, and Pharmacogenomics
    • Pharmaceutical Technology, Analytical Chemistry, and Drug Regulatory Affairs
  2. Allied Sciences:
    • Biotechnology, Microbiology, and Biochemistry
    • Neurosciences, Pathology, and Biomaterial Sciences
    • Health Outcomes Research and Evidence-Based Medicine
    • Environmental Sciences and Green Chemistry (with direct relevance to pharmaceuticals)
  3. Interdisciplinary Research:
    • Emerging areas such as pharmacoinformatics, computational biology, and precision medicine
    • Sustainable practices in pharmaceutical manufacturing, including environmental biotechnology and bioremediation (focused on pharmaceutical waste management)

 

Announcement and Advertisement 

Announcements regarding scientific activities such as conferences, symposium, are published for free. Advertisements can be either published or placed on website as banners.

 

 

Publishing Schedule: 4 issues per year (January, April, July, October).

Top Articles
Impact of a Healthy Lifestyle on the Psychological Well-being of University Students
 Written by Hanawi S. A.   Published on Issue 2 Vol 9, 2020
Health can influence eating habits and also mental and social well-being. This cross-sectional study was conducted to determine the relationship between healthy lifestyle and stress among 173 university students using Simple Lifestyle Indicator Questionnaire (SLIQ) and Depression, Anxiety and Stress Score-42 (DASS-42) to measure their emotional states of depression, anxiety and stress. The results indicated that 71.8% were categorized as having an unhealthy lifestyle and 28.2% an intermediate li Read More
Relationship between Learning Style and Academic Performance among the Generation Z Students in Kuala Lumpur
 Written by Siti Aishah Hanawi   Published on Issue 3 Vol 11, 2022
Every student has a unique learning style. Their personalities are shaped by factors affecting their learning styles. Besides that, it is evident that students’ distinctive learning style has a significant impact on their academic success. A cross-sectional study was done to investigate the degree of association between students’ learning styles and academic achievement. This research was conducted in Kuala Lumpur, and the participants were first- to third-year biomedical science stu Read More
Exploring Recent Updates on Molecular Docking: Types, Method, Application, Limitation & Future Prospects
 Written by Mahendra Kumar Sahu   Published on Issue 2 Vol 13, 2024
Molecular docking serves as a crucial computational tool in the realm of drug discovery and development, aimed at understanding the interactions between small molecules and target proteins. This study delves into the objective of elucidating the evolution of molecular docking techniques, their current applications, and potential future directions. Through a comprehensive review of the literature and analysis of recent advancements, this study provides insights into the methodologies employed in Read More
Digital Childhood: the Impact of Using Digital Technology on Children’s Health
 Written by Nehad Ahmed Ibrahim Zahra   Published on Issue 3 Vol 8, 2019
Background and Objective: Digital media can be considered as an important ‎ element of life for today's children and adolescents since they spend a lot of time ‎ using it. This increased use of digital media is associated with poor behavior and ‎ health status. Society in general and practitioners in public health in particular ‎ should promote digital media use strategies through health education. This study is ‎ aimed at evaluating the impact of using digital technology Read More
Latest Articles
Causal Precision Pharmacotherapy from Genotype to Dose through Phenoconversion, Treatment History, Time-Varying Clinical Context, and Competing Therapeutic Goals
 Written by Peter Nilsson   Published on Issue 2 Vol 14, 2025
Pharmacogenomics can identify inherited determinants of drug disposition, response, and toxicity, but genotype alone cannot specify an optimal treatment for a patient whose functional phenotype, disease state, concomitant therapy, prior exposure, therapeutic priorities, and available options change over time. This Original Causal Decision Architecture Article proposes a Causal Precision Pharmacotherapy Decision Architecture that separates germline information from baseline functional phenotype, Read More
Pharmaceutical Formulation as a Dynamic System Linking Molecular Stability, Process History, Manufacturability, and In-Use Performance throughout the Product Lifecycle
 Written by Rafael Mendoza   Published on Issue 2 Vol 14, 2025
Pharmaceutical formulations are commonly described through composition, manufacturing specifications, critical quality attributes, and stability endpoints. Although these descriptions are necessary, they may inadequately represent products whose molecular organization, physical state, processability, release behavior, and in-use performance depend on the sequence of conditions experienced throughout the product lifecycle. This Original Dynamic-Systems Theory Article proposes that a pharmaceutica Read More
Advanced Pharmaceutical Formulations across Scales: A Scoping Review of Digital Design, Continuous Manufacturing, and Patient-Centric Dosage Forms
 Written by Ahmed Ben Ali   Published on Issue 2 Vol 14, 2025
Advanced pharmaceutical formulations increasingly arise through interactions among material science, computational design, manufacturing technology, biopharmaceutic modelling, and patient-use requirements. This scoping review maps the concepts, technologies, evidence types, development stages, and translational interfaces represented across the literature. A PRISMA-ScR-compatible and JBI-informed approach defined broad mapping questions, eligibility boundaries, information sources, screening log Read More
The Biological Identity Ledger for Tracing Protein Corona Formation, Immune Recognition, Tissue Distribution, and Nanocarrier Fate
 Written by Kristian Eriksen   Published on Issue 2 Vol 14, 2025
Nanocarriers are commonly defined by properties measured before administration, yet their biologically operative identity changes as they encounter proteins, lipids, antibodies, cells, extracellular matrices, and intracellular environments. Fragmented reporting of manufactured attributes, acquired coronas, recognition events, tissue exposure, degradation, and clearance prevents these transformations from being traced as one evidence chain. This Original Evidence Architecture Article proposes the Read More
Important Links
Submit Your Paper Current Issue Table of Content Author's Instruction Copyright Form Join Editorial Board
Search Articles
Associations
Issue 2 Volume 14 (2025)
Issue 3 Volume 14 (2025)
[email protected]